Related Experiment Video
Updated: Jun 16, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
Y L Lo1, S Y Lum, S Fook-Chong
1Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Outram Road, Singapore, Singapore. gnrlyl@sgh.com.sg
The Journal of Headache and Pain
|February 10, 2010
Abstract:
Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.